ANN ARBOR, MI--(Marketwire - November 14, 2008) - Adeona Pharmaceuticals, Inc. (AMEX: AEN), a pharmaceutical company developing innovative late-stage drug candidates for the treatment of autoimmune and central nervous system (CNS) diseases, today announced its clinical update and results for its third quarter of 2008.
